Advancing hope by using genomics and AI to match patients to the latest and most promising biomarker-guided clinical trials.
Supporting clinical decision-making for even the most complex cancer cases. The Providence Molecular Tumor Board brings together experts to develop treatment plans tailored to each unique cancer case.
As your colleagues, we’re available to quickly respond to detailed lab and patient testing questions. The lab is integrated with MyChart and Epic, and includes supportive workflows that simplify ordering, reporting, and communication.
The MGL builds tests based on the requests and feedback of Providence physicians. The lab also supports a wide variety of basic, translational and clinical research studies across the Providence system.
“When faced with rare tumors and complex decision-making, Providence Genomics has been a valuable resource to help me provide personalized and cutting-edge care to my patients.”
